FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3146475449> ?p ?o ?g. }

• W3146475449 endingPage "243" @default.
• W3146475449 startingPage "231" @default.
• W3146475449 abstract "Honokiol (HO) exerts neuroprotective effects in several animal models of Alzheimer's disease (AD), but the poor dissolution hampers its bioavailability and therapeutic efficacy.A novel honokiol nanoscale drug delivery system (Nano-HO) with smaller size and excellent stability was developed in this study to improve the solubility and bioavailability of HO. The anti-AD effects of Nano-HO was determined.Male TgCRND8 mice were daily orally administered Nano-HO or HO at the same dosage (20 mg/kg) for 17 consecutive weeks, followed by assessment of the spatial learning and memory functions using the Morris Water Maze test (MWMT).Our pharmacokinetic study indicated that the oral bioavailability was greatly improved by Nano-HO. In addition, Nano-HO significantly improved cognitive deficits and inhibited neuroinflammation via suppressing the levels of TNF-α, IL-6 and IL-1β in the brain, preventing the activation of microglia (IBA-1) and astrocyte (GFAP), and reducing β-amyloid (Aβ) deposition in the cortex and hippocampus of TgCRND8 mice. Moreover, Nano-HO was more effective than HO in modulating amyloid precursor protein (APP) processing via suppressing β-secretase, as well as enhancing Aβ-degrading enzymes like neprilysin (NEP). Furthermore, Nano-HO more markedly inhibited tau hyperphosphorylation via decreasing the ratio of p-Tau (Thr 205)/tau and regulating tau-related apoptosis proteins (caspase-3 and Bcl-2). In addition, Nano-HO more markedly attenuated the ratios of p-JNK/JNK and p-35/CDK5, while enhancing the ratio of p-GSK-3β (Ser9)/GSK-3β. Finally, Nano-HO prevented the gut microflora dysbiosis in TgCRND8 mice in a more potent manner than free HO.Nano-HO was more potent than free HO in improving cognitive impairments in TgCRND8 mice via inhibiting Aβ deposition, tau hyperphosphorylation and neuroinflammation through suppressing the activation of JNK/CDK5/GSK-3β signaling pathway. Nano-HO also more potently modulated the gut microbiota community to protect its stability than free HO. These results suggest that Nano-HO has good potential for further development into therapeutic agent for AD treatment." @default.
• W3146475449 created "2021-04-13" @default.
• W3146475449 creator A5004560402 @default.
• W3146475449 creator A5007908698 @default.
• W3146475449 creator A5008712473 @default.
• W3146475449 creator A5012856135 @default.
• W3146475449 creator A5024140704 @default.
• W3146475449 creator A5036212714 @default.
• W3146475449 creator A5039952647 @default.
• W3146475449 creator A5045818295 @default.
• W3146475449 creator A5060426525 @default.
• W3146475449 creator A5084722353 @default.
• W3146475449 creator A5091572919 @default.
• W3146475449 date "2022-01-01" @default.
• W3146475449 modified "2023-10-13" @default.
• W3146475449 title "Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer’s disease via inhibiting neuropathology and modulating gut microbiota" @default.
• W3146475449 cites W1424430602 @default.
• W3146475449 cites W1498693902 @default.
• W3146475449 cites W1567624342 @default.
• W3146475449 cites W1946762479 @default.
• W3146475449 cites W1965636186 @default.
• W3146475449 cites W1993050097 @default.
• W3146475449 cites W2008253137 @default.
• W3146475449 cites W2022410893 @default.
• W3146475449 cites W2030087128 @default.
• W3146475449 cites W2036270563 @default.
• W3146475449 cites W2052606222 @default.
• W3146475449 cites W2072996585 @default.
• W3146475449 cites W2095594249 @default.
• W3146475449 cites W2096407545 @default.
• W3146475449 cites W2097867538 @default.
• W3146475449 cites W2131180711 @default.
• W3146475449 cites W2153747061 @default.
• W3146475449 cites W2161919187 @default.
• W3146475449 cites W2166547808 @default.
• W3146475449 cites W2170531576 @default.
• W3146475449 cites W2590659146 @default.
• W3146475449 cites W2690365708 @default.
• W3146475449 cites W2734651019 @default.
• W3146475449 cites W2751127090 @default.
• W3146475449 cites W2761210275 @default.
• W3146475449 cites W2806986089 @default.
• W3146475449 cites W2875421836 @default.
• W3146475449 cites W2893905632 @default.
• W3146475449 cites W2958665365 @default.
• W3146475449 cites W2971264693 @default.
• W3146475449 cites W3002439156 @default.
• W3146475449 cites W3005342570 @default.
• W3146475449 cites W3017386351 @default.
• W3146475449 cites W3031164905 @default.
• W3146475449 cites W3111999719 @default.
• W3146475449 cites W3145424636 @default.
• W3146475449 doi "https://doi.org/10.1016/j.jare.2021.03.012" @default.
• W3146475449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35024199" @default.
• W3146475449 hasPublicationYear "2022" @default.
• W3146475449 type Work @default.
• W3146475449 sameAs 3146475449 @default.
• W3146475449 citedByCount "22" @default.
• W3146475449 countsByYear W31464754492022 @default.
• W3146475449 countsByYear W31464754492023 @default.
• W3146475449 crossrefType "journal-article" @default.
• W3146475449 hasAuthorship W3146475449A5004560402 @default.
• W3146475449 hasAuthorship W3146475449A5007908698 @default.
• W3146475449 hasAuthorship W3146475449A5008712473 @default.
• W3146475449 hasAuthorship W3146475449A5012856135 @default.
• W3146475449 hasAuthorship W3146475449A5024140704 @default.
• W3146475449 hasAuthorship W3146475449A5036212714 @default.
• W3146475449 hasAuthorship W3146475449A5039952647 @default.
• W3146475449 hasAuthorship W3146475449A5045818295 @default.
• W3146475449 hasAuthorship W3146475449A5060426525 @default.
• W3146475449 hasAuthorship W3146475449A5084722353 @default.
• W3146475449 hasAuthorship W3146475449A5091572919 @default.
• W3146475449 hasBestOaLocation W31464754491 @default.
• W3146475449 hasConcept C126322002 @default.
• W3146475449 hasConcept C181389837 @default.
• W3146475449 hasConcept C185592680 @default.
• W3146475449 hasConcept C25498285 @default.
• W3146475449 hasConcept C2776914184 @default.
• W3146475449 hasConcept C2781161787 @default.
• W3146475449 hasConcept C2781334404 @default.
• W3146475449 hasConcept C44752575 @default.
• W3146475449 hasConcept C71924100 @default.
• W3146475449 hasConcept C87753298 @default.
• W3146475449 hasConcept C98274493 @default.
• W3146475449 hasConceptScore W3146475449C126322002 @default.
• W3146475449 hasConceptScore W3146475449C181389837 @default.
• W3146475449 hasConceptScore W3146475449C185592680 @default.
• W3146475449 hasConceptScore W3146475449C25498285 @default.
• W3146475449 hasConceptScore W3146475449C2776914184 @default.
• W3146475449 hasConceptScore W3146475449C2781161787 @default.
• W3146475449 hasConceptScore W3146475449C2781334404 @default.
• W3146475449 hasConceptScore W3146475449C44752575 @default.
• W3146475449 hasConceptScore W3146475449C71924100 @default.
• W3146475449 hasConceptScore W3146475449C87753298 @default.
• W3146475449 hasConceptScore W3146475449C98274493 @default.
• W3146475449 hasFunder F4320321001 @default.
• W3146475449 hasFunder F4320321921 @default.
• W3146475449 hasFunder F4320322942 @default.

• next